Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis

NCT03280927 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate Onychomycosis Due to Dermatophyte

Interventions

DRUG: Jublia®

Sponsor

Dong-A ST Co., Ltd.